HYDROFLUMETHIAZIDE; RESERPINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for hydroflumethiazide; reserpine and what is the scope of patent protection?
Hydroflumethiazide; reserpine
is the generic ingredient in four branded drugs marketed by Usl Pharma, Watson Labs, Ivax Pharms, Par Pharm, and Shire, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.Summary for HYDROFLUMETHIAZIDE; RESERPINE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 5 |
NDAs: | 6 |
DailyMed Link: | HYDROFLUMETHIAZIDE; RESERPINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROFLUMETHIAZIDE; RESERPINE
US Patents and Regulatory Information for HYDROFLUMETHIAZIDE; RESERPINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | HYDROFLUMETHIAZIDE AND RESERPINE | hydroflumethiazide; reserpine | TABLET;ORAL | 088127-001 | Mar 22, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Shire | SALUTENSIN-DEMI | hydroflumethiazide; reserpine | TABLET;ORAL | 012359-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Par Pharm | RESERPINE AND HYDROFLUMETHIAZIDE | hydroflumethiazide; reserpine | TABLET;ORAL | 088907-001 | Sep 20, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Shire | SALUTENSIN | hydroflumethiazide; reserpine | TABLET;ORAL | 012359-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Usl Pharma | HYDROFLUMETHIAZIDE AND RESERPINE | hydroflumethiazide; reserpine | TABLET;ORAL | 088195-001 | Oct 26, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |